Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1607
    -0.0076 (-0.65%)
     
  • GBP/USD

    1.2370
    -0.0068 (-0.55%)
     
  • Bitcoin GBP

    51,883.14
    +534.95 (+1.04%)
     
  • CMC Crypto 200

    1,373.06
    +60.44 (+4.60%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CRUDE OIL

    83.25
    +0.52 (+0.63%)
     
  • GOLD FUTURES

    2,405.30
    +7.30 (+0.30%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

Hyatt's Andaz Brand to Debut in Czech Republic, Eyes Growth

In a bid to maintain its position as the fastest-growing global hospitality company, Hyatt Hotels Corporation H has been strengthening its presence worldwide. Recently, the company announced that one of its affiliates inked a deal with UBM Development AG to develop Hyatt’s first Andaz brand property named Andaz Prague, in Czech Republic.

Notably, this 175-roomed hotel, situated at Senovazne Square, is in the close proximity to Prague’s world-famous Old Town. The property is slated to open in 2022.

Notably, the Andaz brand’s luxury hotel draws inspiration from Prague’s history and cultural traditions, and will mark the first luxury lifestyle hotels in the Czech Capital. “This city of Mozart, Mucha and Hrabal continues to inspire people to explore its rich offerings. With the addition of Andaz Prague, we are excited for Hyatt to have a brand presence in the three imperial cities of Europe – Vienna, Budapest and Prague – and grow our opportunities to cater to the luxury demand.” as stated by Takuya Aoyama, vice president development, Hyatt.

The management also stated that to meet the rising demand of such properties in Europe, the company has unveiled two new properties this year — Andaz Munich Schwabinger Tor and Andaz Vienna Am Belvedere, and will join Andaz London Liverpool Street and Andaz Amsterdam Prinsengracht.

ADVERTISEMENT

Expansion to Spur Growth

Hyatt is also expanding its footprint into the diverse international markets including Asia Pacific, Europe, Africa, the Middle East and Latin America. As of Sep 30, 2019, the company's portfolio included more than 875 properties in 60 countries across six continents.

This apart, the company has announced further expansion plans in Australia, Brazil, Germany, the U.K., Indonesia, Japan, Mexico, Saudi Arabia, Singapore, Thailand, the Netherlands and others.

Meanwhile, the company’s new brand signings have consistently exceeded the openings globally. This trend is expected to continue in the current year and beyond. In 2018, Hyatt registered net room growth of 13.6% on a year-over-year basis. For 2019, it expects unit growth of roughly 7.25-7.75%, reflecting 80 new hotel openings.

In the past six months, shares of Hyatt have gained 11.9% compared with the industry’s 11.6% rally.

Zacks Rank & Stocks to Consider

Hyatt, which shares space with Marriott International, Inc. MAR, has a Zacks Rank #3 (Hold). Better-ranked stocks in the same space include GreenTree Hospitality Group Ltd. GHG and Civeo Corporation CVEO. While Green Tree sports a Zacks Rank #1 (Strong Buy), Civeo carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

GreenTree Hospitality Group has an impressive long-term earnings growth rate of 17.6%.

Civeo reported better-than-expected earnings in three of the trailing four quarters, with average being 42.5%.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Marriott International, Inc. (MAR) : Free Stock Analysis Report
 
Hyatt Hotels Corporation (H) : Free Stock Analysis Report
 
Civeo Corporation (CVEO) : Free Stock Analysis Report
 
GreenTree Hospitality Group Ltd. Sponsored ADR (GHG) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research